| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 3, Issue 9 637-644, Copyright © 1992 by American Association of Cancer Research
ARTICLES |
R Datta, R Hass, H Gunji, R Weichselbaum and D Kufe
Laboratory of Clinical Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.
The cellular responses to ionizing radiation include growth arrest, DNA repair, and lethality. However, little is known about the signaling events responsible for these responses. The present studies have examined the effects of ionizing radiation on the expression of genes involved in cell cycle control. The results demonstrate that the treatment of asynchronous cells with 20 Gy ionizing radiation is associated with transient down-regulation of the cdc2, cyclin A, cyclin B, and cdc25 genes. This effect was associated with transient induction of the c-jun gene. RNA stability studies demonstrate that the down-regulation of gene expression following ionizing radiation exposure is at least in part due to a decrease in transcript half-life. Other studies were performed with elutriated cells enriched for populations in G1 and S phases. Treatment of G1 enriched cell populations with 10 Gy resulted in a selective decrease in cyclin B mRNA levels, whereas this effect on cyclin B expression was less pronounced at 5 Gy and undetectable at 1 Gy. Similar results were obtained with S phase enriched cells. Taken together with clonogenic survival studies, these findings indicate that down-regulation of cell cycle control gene expression is associated with lethality, whereas lower doses of ionizing radiation have little, if any, effect on the expression of these genes. The findings also suggest that DNA damage may activate signaling events which regulate expression of cell cycle control genes.
This article has been cited by other articles:
![]() |
L. Geng, K. C. Cuneo, A. Fu, T. Tu, P. W. Atadja, and D. E. Hallahan Histone Deacetylase (HDAC) Inhibitor LBH589 Increases Duration of {gamma}-H2AX Foci and Confines HDAC4 to the Cytoplasm in Irradiated Non-Small Cell Lung Cancer Cancer Res., December 1, 2006; 66(23): 11298 - 11304. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miyata, Y. Doki, H. Yamamoto, K. Kishi, H. Takemoto, Y. Fujiwara, T. Yasuda, M. Yano, M. Inoue, H. Shiozaki, et al. Overexpression of CDC25B Overrides Radiation-induced G2-M Arrest and Results in Increased Apoptosis in Esophageal Cancer Cells Cancer Res., April 1, 2001; 61(7): 3188 - 3193. [Abstract] [Full Text] |
||||
![]() |
H. Barth, M. Klingler, K. Aktories, and V. Kinzel Clostridium botulinum C2 Toxin Delays Entry into Mitosis and Activation of p34cdc2 Kinase and cdc25-C Phosphatase in HeLa cells Infect. Immun., October 1, 1999; 67(10): 5083 - 5090. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Passalaris, J. A. Benanti, L. Gewin, T. Kiyono, and D. A. Galloway The G2 Checkpoint Is Maintained by Redundant Pathways Mol. Cell. Biol., September 1, 1999; 19(9): 5872 - 5881. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A Boothman, E. Odegaard, C.-R. Yang, K. Hosley, and M. S Mendonca Molecular analyses of adaptive survival responses (ASRs): role of ASRs in radiotherapy Human and Experimental Toxicology, August 1, 1998; 17(8): 448 - 453. [Abstract] [PDF] |
||||
![]() |
M Pagano, A M Theodoras, S W Tam, and G F Draetta Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes & Dev., July 15, 1994; 8(14): 1627 - 1639. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |